Skip to content

Laboratory medicine 2050: from testing to health intelligence network, a vision from the IFCC Emerging Technologies Division

Jul 2026 · Clinical Chemistry and Laboratory Medicine · 1 citation · 66 references
Medicine

TL;DR

Ten megatrends that may shape laboratory medicine by mid-century are explored, including precision multi-omics, AI-supported diagnostics, distributed healthcare models, patient-owned data ecosystems, digital twins, convergence of imaging and laboratory medicine, population-wide prevention strategies, regenerative therapies, sustainability imperatives, and workforce transformation.

Abstract

Abstract Laboratory medicine is undergoing a profound transformation driven by advances in artificial intelligence (AI), automation, and data interoperability. By 2050, laboratories may evolve from analytical testing facilities into an interconnected health intelligence capable of translating biological, digital, and environmental data into more personalized, preventive, and sustainable healthcare solutions. Building on previous foresight analysis conducted by the IFCC Emerging Technologies Division (ETD), global healthcare outlook reports, and expert-informed horizon scanning, this paper explores ten megatrends that may shape laboratory medicine by mid-century. These include precision multi-omics, AI-supported diagnostics, distributed healthcare models, patient-owned data ecosystems, digital twins, convergence of imaging and laboratory medicine, population-wide prevention strategies, regenerative therapies, sustainability imperatives, and workforce transformation. Collectively, these developments represent a paradigm shift from data generation to data interpretation, positioning laboratories as trusted nodes within the health intelligence network connecting patients, clinicians, and healthcare systems. The integration of automation with advanced multi-omics technologies, including robotic liquid handling, autonomous LC-MS/MS platforms, spatial proteomics, and real-time metabolomics, will accelerate the transition toward precision and planetary health. Four exploratory scenarios illustrate plausible trajectories for laboratory medicine in 2050. The Hyper-Intelligent Laboratory explores the implications of self-learning systems and advanced analytics capable of supporting earlier disease prediction and intervention. The Sustainable and Regenerative Laboratory illustrates how environmental stewardship and diagnostic excellence may converge within circular healthcare ecosystems. The Patient-in-the-Loop Revolution examines a future in which citizens become active stewards of their health data and participants in healthcare decision-making. The Spacefaring Laboratory extends this reflection beyond Earth, illustrating how extreme environments may accelerate innovation in autonomous diagnostics, sustainability, and human health monitoring. By 2050, laboratory medicine could serve as a central intelligence layer within healthcare systems, transforming biological signals into actionable knowledge. Achieving this vision will require scientific innovation, regulatory adaptability, equitable access, ethical governance, sustainability, and a future-ready workforce.

View source

Similar papers

Review Open access Aug 2026

ARTIFICIAL INTELLIGENCE IN MODERN MEDICINE: A COMPREHENSIVE REVIEW OF CURRENT APPLICATIONS, CHALLENGES, AND FUTURE PERSPECTIVES

Introduction: The digital transformation of healthcare is accelerating, driven by unprecedented advancements in Artificial Intelligence (AI). From large language models (LLMs) to biomolecular structure prediction, AI is redefining modern diagnostic and therapeutic standards. Aim: This review evaluates the current state of AI applications in medicine, focusing on clinical knowledge encoding, molecular drug discovery, and administrative workflow optimization, while critically addressing the technical, ethical, and systemic challenges of their institutional implementation. Materials and Methods: A structured analysis was conducted utilizing a hybrid approach that combines a multi-decade bibliometric trend perspective with a detailed synthesis of 21 landmark publications, clinical trials, and meta-analyses from high-impact journals. Results: AI demonstrates expert-level performance in medical knowledge retrieval and spatiotemporal diagnostics. AlphaFold 3 has revolutionized computational therapeutics through all-atom biomolecular interaction prediction, while ambient AI scribes significantly reduce physician burnout by automating clinical documentation workflows. However, data-driven "hallucinations" in LLMs and the inherent "black box" nature of deep learning architectures remain critical barriers to autonomous deployment. Conclusions: AI is successfully transitioning from an isolated research tool into an essential clinical "co-pilot." Achieving its full potential in Medicine 4.0 requires robust frameworks for algorithmic explainability, global dataset diversification, and a strategic synergy between machine precision and human clinical judgment.

Aleksandra Stańczyk, Kinga Haduch, Zuzanna Michalska et al. · 0 citations
Review Open access 2026

The evolving landscape of laboratory medicine: A look into the future

Laboratory medicine is undergoing a radical transformation, driven by sustained technological innovation, shifting workforce demographics, increasing diagnostic complexity, and mounting systemic pressures within healthcare delivery systems. Contemporary clinical laboratories have progressively transitioned from predominantly technical service units into highly integrated, data-intensive clinical hubs that generate and interpret information central to a large proportion of medical decisions. In parallel, persistent shortages of qualified personnel, escalating administrative and regulatory demands, growing cybersecurity vulnerabilities, and the rapid integration of automation and artificial intelligence (AI) are redefining professional roles, required competencies, and organisational structures. This personal overview aims to summarise the leading structural and systemic trends currently reshaping laboratory medicine, including workforce sustainability and training gaps, the continuous expansion and stratification of diagnostic testing, the evolving burden of infectious diseases and antimicrobial resistance, and the accelerating implementation of automation and AI-supported diagnostic workflows. It further addresses emerging risks such as cyberattacks targeting healthcare infrastructure and the progressive administrative overload affecting laboratory activities. Collectively, these factors highlight the need for adaptive governance models, resilient laboratory systems, and reinforced clinical orientation of laboratory professionals.

Giuseppe Lippi · 0 citations
Review

Innovative Technologies

Aleksandra Stańczyk, Kinga Haduch, Zuzanna Michalska et al. · 0 citations
Review Open access Aug 2026

Bridging gaps in health artificial intelligence: challenges in MDPI research articles

This study systematically analyzes research trends in health AI over the past six years through a systematic literature review (SLR) and a bibliometric analysis using VOSviewer to highlight dominant research areas, including machine learning for diagnosis, AI-driven hospital management, and predictive analytics.

Irwan Bastian, Aqilla Rahman Musyaffa, Lukman Nulhakim et al. · 0 citations
Review Open access Aug 2026

AI-Enabled Smart Healthcare Systems: Innovative Approaches to Disease Prediction, Accurate Diagnosis, and Effective Public Health Management

It is concluded that AI-driven diagnostic systems have achieved genuine, reproducible performance parity with human specialists on narrow, well-defined tasks, while broader clinical deployment remains constrained by validation, generalizability, and algorithmic-bias challenges that the reviewed literature has only begun to resolve.

Vinit Kumar Ramawat, G.PRABHAKARAN, Pinki Das et al. · 0 citations
Review Open access Jul 2026

Artificial intelligence-based software as a medical device: regulatory evolution toward continuous oversight

This structured narrative review examines how AI-SaMD regulation is moving beyond single-point premarket evaluation toward continuous and dynamic oversight, and synthesizes five evidence dimensions central to ongoing regulatory assurance: data evidence, algorithm evidence, software and cybersecurity evidence, clinical scenario and human factors evidence, and real-world data/real-world evidence with change management.

Yukun Dong, Ping Jiang, Xiao-Hua Zhou · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.